Home / B9D1 Knockout Cell Lines

B9D1 Knockout Cell Lines

Gene: B9D1

Official Full Name: B9 domain containing 1provided by HGNC

Gene Summary: This gene encodes a B9 domain-containing protein, one of several that are involved in ciliogenesis. Alterations in expression of this gene have been found in a family with Meckel syndrome. Meckel syndrome has been associated with at least six different genes. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Mar 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO27851 B9D1 Knockout cell line (HeLa) Human B9D1 1:3~1:6 Negative Online Inquiry
KO27852 B9D1 Knockout cell line (HCT 116) Human B9D1 1:2~1:4 Negative Online Inquiry
KO27853 B9D1 Knockout cell line (HEK293) Human B9D1 1:3~1:6 Negative Online Inquiry
KO27854 B9D1 Knockout cell line (A549) Human B9D1 1:3~1:4 Negative Online Inquiry

Background

B9D1 Gene Knockout Cell Lines are genetically engineered cell lines characterized by the targeted disruption of the B9D1 gene, a critical component involved in the regulation of cellular processes such as proliferation and apoptosis. Utilizing CRISPR-Cas9 technology, these cell lines allow researchers to create a precise genetic knockout, facilitating in-depth studies of the B9D1 gene's physiological roles and its impact on the cellular microenvironment.

The primary function of B9D1 Gene Knockout Cell Lines lies in their ability to provide valuable insights into gene function through loss-of-function experiments. By eliminating the B9D1 gene, researchers can observe phenotypic changes, assess signaling pathways, and evaluate the cellular response to varying stimuli. This mechanistic understanding is critical in cellular biology, cancer research, and drug development, where delineating gene function is paramount in elucidating disease mechanisms.

The scientific importance of these cell lines extends into clinical applications, particularly in the study of genetic disorders and the exploration of potential therapeutic targets. B9D1 is implicated in multiple pathologies, making the knockout model a vital tool for evaluating the implications of B9D1 deficiency in disease and for the development of targeted therapies.

Compared to alternative methods, such as RNA interference or chemical inhibitors, B9D1 Gene Knockout Cell Lines provide a more stable and permanent solution, eliminating the need for transient expression and ensuring consistent results across experiments. This stability is crucial for reproducibility and ensures the reliability of experimental outcomes.

For researchers and clinicians seeking to advance their work in genetic research and therapeutic development, B9D1 Gene Knockout Cell Lines offer a unique opportunity to engage with a robust and validated model. They exemplify precision in genetic manipulation, alleviating the challenges of studying gene function in vivo.

Our company specializes in providing high-quality biological products supported by extensive research. With a strong commitment to excellence and innovation, we offer a comprehensive range of genetically modified cell lines to empower your research and drive advancements in biological sciences.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.